UCB and IBM today announced the completion of the initial phase of a project designed to harness the power of analytics to help healthcare providers deliver more highly personalized care to people living with epilepsy. The milestone marks the critical first step in the path towards eventually harnessing the transformative power of cognitive computing capabilities, such as IBM Watson, for epilepsy care.
FARMERS BRANCH, Texas, May 15, 2013 /PRNewswire/ -- Effective July 1, CCS Medical, a leading provider of home delivery medical equipment and supplies, will be one of only 18 Medicare mail order suppliers providing diabetic testing supplies nationwide.
PENTAX Medical Company, a healthcare industry leader in endoscopic imaging, announces the U.S. launch of the EPK-i®5010 Video Processor with PENTAX i-SCAN™, the industry's highest* resolution HD+ imaging technology for flexible endoscopy.
Paula Spurlock was experiencing intense itching following hip replacement surgery. It turned out that she was allergic to the hip implant and the bone cement used to keep the implant in place. Now, a new test can help to prevent this type of problem for future patients who require an orthopedic implant.
A growing number of patients learn of allergies to new hips and knees only after surgery is done. Imagine what Paula Spurlock must have been going through. Shortly after having a hip replaced in 2011, the trouble started. "I had horrible itching, really bad migraines and intense pain throughout my body," she said. "I couldn't take it. Every single thing in me itched."
ApoCell Announces Delivery of First Prototypes of ApoStreamT Circulating Tumor Cell (CTC) Isolation Technology to National Cancer InstituteMay 15, 2013 8:00 am | by The Associated Press | News | Comments
ApoCell, Inc. announced that the first prototypes of its ApoStreamT circulating tumor cell (CTC) isolation system have been delivered to select investigator sites including SAIC-Frederick Inc. (SAIC-F) in support of the National Cancer Institute (NCI). The delivery is part of a $2.9 million ...
Emphasis on X-Ray Quality Spurs Adoption of Computed and Digital Radiography in Europe, Finds Frost & SullivanMay 15, 2013 4:07 am | by Bio-Medicine.Org | News | Comments
LONDON , May 15, 2013 /- The need to improve the efficiency and quality of X-ray examinations will drive healthcare facilities across Europe to install computed radiography (CR) and digital radiography (DR) systems. The emergence of retrofit systems based on flat panel technology has popularised DR systems, and will sustain investments in the European computed and digita...
Alloys like bronze and steel have been transformational for centuries, yielding top-of-the-line machines necessary for industry. As scientists move toward nanotechnology, however, the focus has shifted toward creating alloys at the nanometer scale—producing materials with properties unlike their predecessors.
The government has halted a study testing treatments for a brain condition that can cause strokes after early results suggested invasive therapies were riskier than previously thought. The condition involves a kind of tangle in the brain called an arteriovenous malformation, or AVM. Arteries and veins grow knotted together until eventually some of them burst, causing a bleeding stroke.
New approaches to applying noninvasive imaging tests such as computed tomography, magnetic resonance, and positron emission tomography may play a bigger role in evaluating and managing patients with diabetes. Advances in noninvasive imaging technology can assess important changes in fat composition and distribution in the body that may affect the metabolic complications and diseases associated with diabetes.
Digital direct radiography is significantly more effective than computed radiography at detecting breast cancer, according to a new study published online in the journal Radiology. The findings are the first to show a difference between the two types of digital imaging when compared with screen film mammography and suggest that women should be informed of the potential for lower cancer detection with CR, the researchers said.
NVISION Laser Eye Centers First in the Nation to Offer Avellino-GENE Detection System Test to Protect Patients from BlindnessMay 14, 2013 8:04 am | by PR Newswire | News | Comments
MENLO PARK, Calif., May 14, 2013 /PRNewswire/ -- Avellino Lab USA, developer of the only genetic test available worldwide for Avellino Corneal Dystrophy (ACD), today announced that California-based NVISION Laser Eye Centers is the first provider in the United States to offer patients...
Ceramic injection molded products are increasingly being used in the manufacture of innovative medical components and devices, thanks to the unique range of material and performance attributes. In this article, the material, its key features, and the growing range of applications for which it is suited are highlighted.
It’s no secret that getting a medical device to market can be a lengthy, frustrating process. Facing the new medical device excise tax and lack of clarity from the FDA around regulatory policies, medtech startups are now starting to rethink launching in the U.S.
Researchers at the University of Bristol have led a new enquiry into how extremely small particles of silica (sand) can be used to design and construct artificial protocells in the laboratory. The work is described in an article published in Nature Chemistry.
From brain to heart to stomach, the bodies of humans and animals generate weak magnetic fields that a supersensitive detector could use to pinpoint illnesses, trace drugs – and maybe even read minds. Sensors no bigger than a thumbnail could map gas deposits underground, analyze chemicals, and pinpoint explosives that hide from other probes.
NEC Display Solutions Receives FDA 510(k) Clearance on MD211C2 and MD211C3 Medical Diagnostic MonitorsMay 9, 2013 12:00 pm | by The Associated Press | News | Comments
CHICAGO--(BUSINESS WIRE)--May 9, 2013--NEC Display Solutions of America, a leading provider of commercial LCD display and projector solutions, announced today the Food and Drug Administration 510(k) market clearance of the 21-inch MultiSync® MD211C2 and MD211C3 medical-grade monitors, built for...
Researchers have discovered a technique for controlling the sensitivity of graphene chemical sensors. The sensors, made of an insulating base coated with a graphene sheet--a single-atom-thick layer of carbon--are already so sensitive that they can detect an individual molecule of gas.
Covidien, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, has launched the Microstream® MicroPod™ module. This is an important product for its Original Equipment Manufacturer (OEM) partners that will help hospitals improve patient safety by expanding access to capnography technology.
The primary care practitioner is well poised to be the central point-of-care, aiding a more holistic approach to the patient. However, the patient demand curve will quickly outstrip the supply of practitioners in even the best treatment models. An enhanced approach is necessary, one that enables patient self-management combined with efficiency tools for HCPs.
Axeda Corporation, the leading provider of cloud-based service and software for managing connected products and delivering machine-to-machine (M2M) applications, today announced that Varian Medical Systems, a leading manufacturer of medical devices and software for treating cancer and other...
SAN DIEGO, May 8, 2013 /PRNewswire/ -- GenomeDx Biosciences today announced that data presented by Johns Hopkins University School of Medicine researchers at the 2013 Annual Meeting for the American Urological Association demonstrated that Decipher™, a transformative genomic test...
Exosome Diagnostics Presents Data Demonstrating Utility of Urine Exosome Technology to Predict Prostate Biopsy Outcome at American Urological Association Annual MeetingMay 8, 2013 11:00 am | by PR Newswire | News | Comments
NEW YORK, May 8, 2013 /PRNewswire/ -- Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic products for use in personalized medicine research and clinical diagnostics, today announced the presentation of data at the American Urological Association Annual...
On May 8th, JoVE published research that demonstrates how a biosensor can detect antibiotic resistance in bacteria. This new technology is a preliminary step in identifying and fighting superbugs, a major public health concern that has led to more deaths than AIDS in the United States in recent years.
A new genomic test for prostate cancer can help predict whether men are more likely to harbor an aggressive form of the disease, according to a new UC San Francisco study. The test, which improves risk assessment when patients are first diagnosed, can also aid in determining which men are suitable for active surveillance.